About Intraflagellar transport-associated protein
Intraflagellar transport-associated protein (IFTAP) is a protein
from Homo sapiens identified by UniProt accession
Q86VG3, 221 residues long.
MolForge cross-references it against 0 known binders and
84 disease associations.
Target properties
| Protein name | Intraflagellar transport-associated protein |
| UniProt accession | Q86VG3 |
| Gene | IFTAP |
| Organism | Homo sapiens |
| Length | 221 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (84)
Diseases linked to this target (Open Targets).
- 3-hydroxypropylmercapturic acid measurement · score 0.37
- PHF-tau measurement · score 0.26
- severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive · score 0.15
- histiocytic medullary reticulosis · score 0.15
- cortical surface area measurement · score 0.13
- cortical thickness · score 0.12
- high density lipoprotein cholesterol measurement · score 0.12
- brain measurement · score 0.10
- azoospermia · score 0.09
- male infertility with teratozoospermia due to single gene mutation · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86VG3-F1 | alphafold | PREDICTED | 66.09 | — |
Amino-acid sequence (221 residues)
MSAHMSGLEI MDEDQLIKDV LDKFLNCHEQ TYDEEFLNTF THLSQEDHVS KRGVFGTDSS ENIFTSAKVT HKNEADDYHL RNKTIFLRTS SQCLEEQVDN FLDLEDLDMD EEIKPQMSED LLLLPGEVEQ DVSTSIPSCI PFVAQPPTCE VKPKPSVKRM DKQTEEILGD EVQLFSLDEE FDYDNVMLTS KFSPAEIENI KELCKQQKRK DTSPDLEKSC D
Explore Intraflagellar transport-associated protein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets